Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Diplomasi FOMO Prabowo: Simbolis, reaktif, berisiko mengancam legitimasi

Presiden Prabowo Subianto menghadiri BRICS Leaders Virtual Meeting dari kediaman pribadinya di Kertanegara, Jakarta Selatan, pada Senin, 8 September 2025.Cahyo/Biro Pers Sekretariat Presiden, CC BY ...

Anak ikut demo: Peran negara dalam memfasilitasi dan melindungi aksi protes

(David Wadie Fisher-Freberg/Wikimedia Commons), CC BY● Banyak anak dalam demonstrasi menjadi korban kekerasan dan penyimpangan hukum.● Demonstrasi bukanlah ruang aman, tapi larangan justru...

Bagaimana revisi KUHAP bisa memperparah pelemahan KPK

(Arraihansyah/Shutterstock)● Revisi KUHAP menjadikan penyidik KPK di bawah kendali polisi, tak lagi independen.● Upaya paksa seperti penyelidikan hingga penyadapan dalam revisi KUHAP membu...